000 nab a22 7a 4500
999 _c16748
_d16748
003 PC16748
005 20220314121615.0
008 220314b xxu||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _91509
_aMancebo Sierra, Esther
_eInmunología
100 _91508
_aAllende Martínez, Luis Miguel
_eInmunología
100 _91510
_aPaz Artal, Estela
_eInmunología
245 0 0 _aActivated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection.
_h[artículo]
260 _bTransplantation proceedings,
_c2015
300 _a47(8):2380-1.
500 _aFormato Vancouver: Boix F, Millan O, San Segundo D, Mancebo E, Miras M, Rimola A et al. Activated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection. Transplant Proc. 2015 Oct;47(8):2380-1.
501 _aPMID: 26518933
504 _aContiene 5 referencias
520 _aActivated regulatory T cells (aTregs) are nowadays a hot topic in organ transplantation to establish their role during acute rejection (AR) episodes. The aim of this multi-center study was to monitor the frequency of aTregs within the first year after transplantation in a cohort of first-time liver transplant recipients enrolled from 2010 to 2012. aTregs frequency was analyzed by means of flow cytometry. Patients who had AR showed higher levels of aTregs during first year after transplantation in comparison with patients who did not have higher levels. High levels of aTregs in liver recipients might be used as a biomarker of AR; however, further studies must be done to address the potential role of aTregs as biomarkers of AR in liver transplantation.
710 _9395
_aServicio de Inmunología
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16748.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0